搜索结果：antimicrobial

Antimicrobial resistance threatens healthcare sustainability and motivates low-cost computational discovery of antimicrobial peptides (AMPs). De novo peptide generation must optimize antimicrobial activity and safety through low predicted toxicity, but likelihood-trained generators do not enforce these goals explicitly. We introduce ProDCARL, a reinforcement-learning alignment framework that couples a diffusion-based protein generator (EvoDiff OA-DM 38M) with sequence property predictors for AMP activity and peptide toxicity. We fine-tune the diffusion prior on AMP sequences to obtain a domain-aware generator. Top-k policy-gradient updates use classifier-derived rewards plus entropy regularization and early stopping to preserve diversity and reduce reward hacking. In silico experiments show ProDCARL increases the mean predicted AMP score from 0.081 after fine-tuning to 0.178. The joint high-quality hit rate reaches 6.3\% with pAMP $>$0.7 and pTox $<$0.3. ProDCARL maintains high diversity, with $1-$mean pairwise identity equal to 0.929. Qualitative analyses with AlphaFold3 and ProtBERT embeddings suggest candidates show plausible AMP-like structural and semantic characteristic

Purpose: Antimicrobial resistance is a major global health concern, affecting hospital admissions and treatment success. This study aims to introduce an experimental setup for monitoring bacterial activity over time using image-based contrast as a key biomarker. Methods: The proposed method captures changes in bacterial activity by analyzing variations in image contrast. The approach is evaluated for its ability to detect antimicrobial effects over shorter time intervals compared to conventional clinical techniques. Results: The findings reveal a progressive decrease in contrast over time, suggesting its potential as an indicator of antimicrobial activity. The results highlight the method's capability for early detection of bacterial susceptibility. Conclusion: The study demonstrates that image-based contrast analysis can serve as a rapid and reliable tool for antimicrobial susceptibility testing, offering advantages over traditional methods in clinical practice.

Antimicrobial peptides have emerged as promising molecules to combat antimicrobial resistance. However, fragmented datasets, inconsistent annotations, and the lack of standardized benchmarks hinder computational approaches and slow down the discovery of new candidates. To address these challenges, we present the Expanded Standardized Collection for Antimicrobial Peptide Evaluation (ESCAPE), an experimental framework integrating over 80.000 peptides from 27 validated repositories. Our dataset separates antimicrobial peptides from negative sequences and incorporates their functional annotations into a biologically coherent multilabel hierarchy, capturing activities across antibacterial, antifungal, antiviral, and antiparasitic classes. Building on ESCAPE, we propose a transformer-based model that leverages sequence and structural information to predict multiple functional activities of peptides. Our method achieves up to a 2.56% relative average improvement in mean Average Precision over the second-best method adapted for this task, establishing a new state-of-the-art multilabel peptide classification. ESCAPE provides a comprehensive and reproducible evaluation framework to advance A

Antimicrobial stewardship (AMS) is critical in pediatric intensive care units (PICUs), where diagnostic uncertainty often drives broad-spectrum antibiotic use, increasing antimicrobial resistance and potential long-term harms. Machine learning offers a promising approach for identifying patient-level opportunities for stewardship interventions from electronic health record data, yet prior work has focused largely on adult populations and static tabular representations. We present a systematic benchmarking study of AMS intervention prediction in the PICU across a public dataset and a private institutional cohort. We define four clinically relevant proxy targets for reducing antibiotic exposure: intravenous-to-oral switching, de-escalation, discontinuation, and short-course therapy. Under a unified evaluation framework, we compare tabular, sequence-based, and graph-based temporal models at multiple temporal resolutions. We find that predictive performance is driven primarily by target prevalence and dataset characteristics rather than model complexity. Sequence models improve the precision-recall trade-off over tabular approaches at coarse (24-hour) resolution, while finer temporal m

We introduce and discuss a kinetic framework describing the time evolution of the statistical distributions of a population divided into the compartments of susceptible, infectious, recovered, and resistant in the presence of a microbial infection driven by susceptible infectious interactions. Our main objective is to quantify the impact of excessive and inappropriate antimicrobial use, which accelerates the spread of resistance by enabling a fraction of infectious individuals to transition into the resistant compartment. The model consists of a system of Boltzmann type equations capturing binary interactions between susceptible and infectious individuals, complemented by linear redistribution operators that represent recovery, the development of resistance, and reinfection processes. In the grazing collision limit, we show that this Boltzmann system is well approximated by a system of coupled Fokker Planck equations. This limiting description allows for a more tractable analysis of the dynamics, including the characterization of the long-time behavior of the population densities. Our analysis highlights how interaction terms drive the system toward a stable equilibrium and quantif

Antimicrobial resistance causes to over a million deaths annually. Antimicrobial peptides (AMPs) are a promising solution, but generative AMP models are not yet ready to design peptides with non-natural amino acids and/or chemical modifications, which are essential for real-world peptide drugs. We present AMPGAN v3, a multi-objective conditional GAN that expands the generative vocabulary to D-amino acids and N/C-terminus modifications such as amidation. By separating adversarial and activity-aware supervision across two specialized discriminators, AMPGAN v3 substantially improves training stability and outperforms prior generative AMP models on external classifiers. We validated five candidates spanning three structural classes in vitro; two showed activity against Gram-positive strains, with the best candidate reaching MIC 8 μg/mL against B. subtilis. To support downstream curation, we further present PepCraft, a multi-agent framework for end-to-end AMP discovery in which a Planning Agent orchestrates specialized executors for generation, filtering, and verification. Its prioritization recommendations align with our in vitro outcomes. Together, these contributions let us examine,

Antibiotics are a vital class of drugs closely associated with the prevention and treatment of bacterial infections. Accurate prediction of molecular antimicrobial activity remains a key challenge in the pursuit of novel antibiotic candidates. However, laboratory-based antimicrobial compounds identification is costly, time-consuming, and prone to rediscovering known antibiotics, highlighting the urgent need for efficient and accurate computational models. Recent advances in machine learning (ML) and deep learning (DL) have significantly enhanced the ability to explore chemical space and identify potential antimicrobial compounds. In this study, we particularly emphasize deep learning models and employ five chemistry language models tailored for chemical data to encode small molecules. Our model incorporates a unique capsule network architecture and introduces innovations in loss function selection and feature processing modules, demonstrating superior performance in predicting inhibitory activities against Escherichia coli and Acinetobacter baumannii. We conducted a series of ablation studies to elucidate the contributions of network design and input features. Case studies validate

Peanut hulls, also known as Arachis hypogaea L. particles (AHL), are an abundant biomass source with a long shelf life. In this study, we incorporate peanut hull powder into PLA polymer, imparting recyclability, biodegradability, and biocompatibility, along with the antimicrobial properties of AHL particles. In particular, we treat AHL particles as a reinforcement for PLA polymer to produce 3D printing filament compatible with the fused filament fabrication (FFF) 3D printing method. We provide a step-by-step method for preparing AHL particles, incorporating them into PLA, and ultimately forming high-quality filaments. We assess the quality of the filaments in terms of extruded dimensions, mechanical strength, and elastic modulus, along with physical properties such as porosity and melt flow index. We evaluate the printability and wettability of the filaments as well. Notably, and unlike other biomass-based reinforcements in PLA, AHL preserves the filament's strength and enhances its elastic modulus. 3D-printed components fabricated using our PLA-AHL filaments successfully retain their antimicrobial properties and exhibit increased overall hardness. However, this comes at the expens

This work studies fundamental questions regarding the optimal design of antimicrobial treatment protocols, using standard pharmacodynamic and pharmacokinetic mathematical models. We consider the problem of designing an antimicrobial treatment schedule to achieve eradication of a microbial infection, while minimizing the area under the time-concentration curve (AUC). We first solve this problem under the assumption that an arbitrary antimicrobial concentration profile may be chosen, and prove that the 'ideal' concentration profile consists of a constant concentration over a finite time duration, where explicit expressions for the optimal concentration and the time duration are given in terms of the pharmacodynamic parameters. Since antimicrobial concentration profiles are induced by a dosing schedule and the antimicrobial pharmacokinetics, the ideal concentration profile is not strictly feasible. We therefore also investigate the possibility of achieving outcomes which are close to those provided by the ideal concentration profile,using a bolus+continuous dosing schedule, which consists of a loading dose followed by infusion of the antimicrobial at a constant rate. We explicitly fin

Generative deep learning techniques have demonstrated an impressive capacity for tackling biomolecular design problems in recent years. Despite their high performance, however, they still suffer from a lack of interpretability and rigorous quantification of associated search spaces, which are necessary to unlock their full potential for scientific inquiry beyond efficient design. An area in which they are of particular interest is in the design of antimicrobial peptides, which are a promising class of therapeutics to treat bacterial infections. Discovering and designing such peptides is difficult because of the vast number of possible sequences and comparatively small amount of experimental information. In this work, we perform a theoretical investigation of latent Bayesian optimization for searching through peptide sequence spaces, with a focus on antimicrobial peptides. We investigate (1) whether searching through a dimensionally-reduced variant of the latent design space may facilitate optimization, (2) how organizing latent spaces by differing amounts of more and less relevant information may improve the efficiency of arriving at an optimal peptide design, and (3) the interpret

The Antibiotic Resistance Microbiology Dataset (ARMD) is a de-identified resource derived from electronic health records (EHR) that facilitates research in antimicrobial resistance (AMR). ARMD encompasses big data from adult patients collected from over 15 years at two academic-affiliated hospitals, focusing on microbiological cultures, antibiotic susceptibilities, and associated clinical and demographic features. Key attributes include organism identification, susceptibility patterns for 55 antibiotics, implied susceptibility rules, and de-identified patient information. This dataset supports studies on antimicrobial stewardship, causal inference, and clinical decision-making. ARMD is designed to be reusable and interoperable, promoting collaboration and innovation in combating AMR. This paper describes the dataset's acquisition, structure, and utility while detailing its de-identification process.

Consumption of antimicrobial drugs, such as antibiotics, is linked with antimicrobial resistance. Surveillance of antimicrobial drug consumption is therefore an important element in dealing with antimicrobial resistance. Many countries lack sufficient surveillance systems. Usage of web mined data therefore has the potential to improve current surveillance methods. To this end, we study how well antimicrobial drug consumption can be predicted based on web search queries, compared to historical purchase data of antimicrobial drugs. We present two prediction models (linear Elastic Net, and non-linear Gaussian Processes), which we train and evaluate on almost 6 years of weekly antimicrobial drug consumption data from Denmark and web search data from Google Health Trends. We present a novel method of selecting web search queries by considering diseases and drugs linked to antimicrobials, as well as professional and layman descriptions of antimicrobial drugs, all of which we mine from the open web. We find that predictions based on web search data are marginally more erroneous but overall on a par with predictions based on purchases of antimicrobial drugs. This marginal difference corres

There is a pressing need to better understand how microbial populations respond to antimicrobial drugs, and to find mechanisms to possibly eradicate antimicrobial-resistant cells. The inactivation of antimicrobials by resistant microbes can often be viewed as a cooperative behavior leading to the coexistence of resistant and sensitive cells in large populations and static environments. This picture is however greatly altered by the fluctuations arising in volatile environments, in which microbial communities commonly evolve. Here, we study the eco-evolutionary dynamics of a population consisting of an antimicrobial resistant strain and microbes sensitive to antimicrobial drugs in a time-fluctuating environment, modeled by a carrying capacity randomly switching between states of abundance and scarcity. We assume that antimicrobial resistance is a shared public good when the number of resistant cells exceeds a certain threshold. Eco-evolutionary dynamics is thus characterised by demographic noise (birth and death events) coupled to environmental fluctuations which can cause population bottlenecks. By combining analytical and computational means, we determine the environmental conditi

Clinical antimicrobial therapy requires the dynamic integration of pathogen profiles,host factors, pharmacological properties of antimicrobials,and the severity of infection. This complexity imposes fundamental limitations on the applicability of Large Language Models (LLMs) in high-stakes clinical decision-making including knowledge gaps, data privacy concerns, high deployment costs, and limited reasoning capabilities. To address these challenges, we propose KRAL (Knowledge and Reasoning Augmented Learning), a low-cost, scalable, privacy-preserving paradigm that leverages teacher-model reasoning to automatically distill knowledge and reasoning trajectories via answer-to-question reverse generation, employs heuristic learning for semi-supervised data augmentation (reducing manual annotation requirements by approximately 80%), and utilizes agentic reinforcement learning to jointly enhance medical knowledge and reasoning while optimizing computational and memory efficiency. A hierarchical evaluation employing diverse teacher-model proxies reduces assessment costs, while modular interface design facilitates seamless system updates. Experimental results demonstrate that KRAL significan

Inspired by the natural defence strategies of insect wings and plant leaves, nanostructured surfaces have emerged as a promising tool in various fields, including engineering, biomedical sciences, and materials science to combat bacterial contamination and disrupt biofilm formation. However, the development of effective antimicrobial surfaces against fungal and viral pathogens presents distinct challenges, necessitating tailored approaches. Here, we aimed to review the recent advancements of the use of nanostructured surfaces to combat microbial contamination, particularly focusing on their mechanobactericidal and antifungal properties, as well as their potential in mitigating viral transmission. We comparatively analysed the diverse geometries and nano-architectures of these surfaces and discussed their applications in various biomedical contexts, such as dental and orthopedic implants, drug delivery systems, and tissue engineering. Our review highlights the importance of preventing microbial attachment and biofilm formation, especially in the context of rising antimicrobial resistance and the economic impact of biofilms. We also discussed the latest progress in material science,

Antimicrobial resistance (AMR) poses a mounting global health crisis, requiring rapid and reliable prediction frameworks that capture its complex evolutionary dynamics. Traditional antimicrobial susceptibility testing (AST), while accurate, remains laborious and time-consuming, limiting its clinical scalability. Existing computational approaches, primarily reliant on single nucleotide polymorphism (SNP)-based analysis, fail to account for evolutionary drivers such as horizontal gene transfer (HGT) and genome-level interactions. This study introduces a novel Evolutionary Mixture of Experts (Evo-MoE) framework that integrates genomic sequence analysis, machine learning, and evolutionary algorithms to model and predict AMR evolution. A Mixture of Experts model, trained on labeled genomic data for multiple antibiotics, serves as the predictive core, estimating the likelihood of resistance for each genome. This model is embedded as a fitness function within a Genetic Algorithm designed to simulate AMR development across generations. Each genome, encoded as an individual in the population, undergoes mutation, crossover, and selection guided by predicted resistance probabilities. The resu

Endophytes are tiny organisms present in living tissues of distinct plants and have been extensively studied for their endophytic microbial complement. Roots of Rosmarinus officinalis were subjected to the isolation of endophytic fungi and screened for antimicrobial activity against Gram-positive (Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae) bacteria. Genomic DNA from active fungal strain of Trichoderma harzianum was isolated, and the internal transcribed spacer (ITS) region was amplified using ITS4 and ITS5 primers and sequenced for genetic inference in fungus. The crude extract of T. harzianum isolate with Ethyl acetate was showed significant antimicrobial activity against P. aeruginosa, S. aureus, K. pneumonia, B. subtilis and E. coli. The antimicrobial activity was highest against P. aeruginosa at concentration of 40 microgram/ ml, followed by S. aureus and K. pneumonia at the same concentration. The lowest antimicrobial activity was against by S. aureus at concentration of 60 microgram/ ml. The current study is confirmed that the antimicrobial activity is due to bioactive compounds founded in e

The bactericidal potency of ionic liquids (ILs) is well-established, yet their precise mechanism of action remains elusive. Here, we show evidence that the bactericidal action of ILs primarily involves permeabilizing the bacterial cell membrane. Our findings reveal that ILs exert their effects by directly interacting with the lipid bilayer and enhancing the membrane dynamics. Lateral lipid diffusion is accelerated which in turn augments membrane permeability, ultimately leading to bacterial death. Furthermore, our results establish a significant connection: an increase in the alkyl chain length of ILs correlates with a notable enhancement in both lipid lateral diffusion and antimicrobial potency. This underscores a compelling correlation between membrane dynamics and antimicrobial effectiveness, providing valuable insights for the rational design and optimization of IL-based antimicrobial agents in healthcare applications.

The evolution of antimicrobial resistance can be strongly affected by variations of antimicrobial concentration. Here, we study the impact of periodic alternations of absence and presence of antimicrobial on resistance evolution in a microbial population, using a stochastic model that includes variations of both population composition and size, and fully incorporates stochastic population extinctions. We show that fast alternations of presence and absence of antimicrobial are inefficient to eradicate the microbial population and strongly favor the establishment of resistance, unless the antimicrobial increases enough the death rate. We further demonstrate that if the period of alternations is longer than a threshold value, the microbial population goes extinct upon the first addition of antimicrobial, if it is not rescued by resistance. We express the probability that the population is eradicated upon the first addition of antimicrobial, assuming rare mutations. Rescue by resistance can happen either if resistant mutants preexist, or if they appear after antimicrobial is added to the environment. Importantly, the latter case is fully prevented by perfect biostatic antimicrobials th